Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW

作者:Stilgenbauer Stephan; Cymbalista Florence; Leblond Veronique; Delmer Alain; Mack Silja; Buehler Andreas; Winkler Dirk; Zenz Thorsten; Busch Raymonde; Ibach Stefan; Choquet Sylvain; Caroline Dartigeas; Cazin Bruno; Tournilhac Olivier; Seiler Till M; Zirlik Katja; Alt Juergen; Soekler Martin; Schetelig Johannes; Dreger Peter; Hallek Michael; Doehner Hartmut
来源:54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), 2012-12-08 to 2012-12-11.